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STUDY QUESTION: Does the risk of low birth weight and premature birth increase with age among mothers who conceive through
medically assisted reproduction (MAR)?
SUMMARY ANSWER: Among MAR mothers, the risk of poorer birth outcomes does not increase with maternal age at birth except at
very advanced maternal ages (40+).
WHAT IS KNOWN ALREADY: The use of MAR treatments has been increasing over the last few decades and is especially diffused
among women who conceive at older ages. Although advanced maternal age is a well-known risk factor for adverse birth outcomes in natural
pregnancies, only a few studies have directly analysed the maternal age gradient in birth outcomes for MAR mothers.
STUDY DESIGN, SIZE, DURATION: The base dataset was a 20% random sample of households with at least one child aged 0–14 at the
end of 2000, drawn from the Finnish population register and other administrative registers. This study included children who were born in
1995–2000, because the information on whether a child was conceived through MAR or naturally was available only from 1995 onwards.
PARTICIPANTS/MATERIALS, SETTING, METHODS: The outcome measures were whether the child had low birth weight (LBW,
<2500 g at birth) and whether the child was delivered preterm (<37 weeks of gestation). Conceptions through MAR were identified by
examining data on purchases of prescription medication from the National Prescription Register. Linear probability models were used to
analyse and compare the maternal age gradients in birth outcomes of mothers who conceived through MAR or naturally before and after
adjustment for maternal characteristics (i.e. whether the mother suffered from acute/chronic conditions before the pregnancy, household
income and whether the mother smoked during pregnancy).
MAIN RESULTS AND THE ROLE OF CHANCE: A total of 56 026 children, 2624 of whom were conceived through MAR treatments,
were included in the study. Among the mothers who used MAR to conceive, maternal age was not associated with an increased risk of LBW
(the overall prevalence was 12.6%) at ages 25–39. For example, compared to the risk of LBW at ages 30–34, the risk was 0.22 percentage
points lower (95% CI: −3.2, 2.8) at ages 25–29 and was 1.34 percentage points lower (95% CI: −4.5, 1.0) at ages 35–39. The risk of LBW
was increased only at maternal ages ≥40 (six percentage points, 95% CI: 0.2, 12). Adjustment for maternal characteristics only marginally
attenuated these associations. In contrast, among the mothers who conceived naturally, the results showed a clear age gradient. For example,
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compared to the risk of LBW (the overall prevalence was 3.3%) at maternal ages 30–34, the risk was 1.1 percentage points higher (95% CI:
0.6, 1.6) at ages 35–39 and was 1.5 percentage points higher (95% CI: 0.5, 2.6) at ages ≥40. The results were similar for preterm births.
LIMITATIONS, REASON FOR CAUTION: A limited number of confounders were included in the study because of the administrative
nature of the data used. Our ability to reliably distinguish mothers based on MAR treatment type was also limited.
WIDER IMPLICATIONS OF THE FINDINGS: This is the first study to analyse the maternal age gradient in the risk of adverse birth
outcomes among children conceived through MAR using data from a nationally representative sample and controlling for important maternal
health and socio-economic characteristics. This topic is of considerable importance in light of the widespread and increasing use of MAR
treatments.
STUDY FUNDING/COMPETING INTEREST(S): Funding for this project was provided by the European Research Council (grant no.
803959 MARTE to Alice Goisis and grant no. 336475 COSTPOST to Mikko Myrskylä). E.S. reports personal fees from Theramex, personal
fees from Merck Serono, personal fees from Health Reimbursement Arrangement, non-financial support from Merck Serono and grants from
Ferring, grants from Theramex, outside the submitted work. The remaining authors have no competing interests.
TRIAL REGISTRTION NUMBER: N/A
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factors
Introduction
The use of medically assisted reproduction (MAR)—i.e. reproduction
through treatments such as ovulation induction, intrauterine insemina-
tion, IVF and ICSI—has increased markedly over the last four decades.
Since 1978, when the first IVF baby was born, more than 8 million
babies have been born afterMAR treatments, and the babies conceived
through MAR now account for more than 7% of all births in some
European countries, such as Denmark and Belgium (De Geyter et al.,
2018).
Women who conceive through MAR are, on average, older than
women who conceive naturally, as fertility treatments are often used
in response to age-related infertility or subfertility problems (Luke and
Brown 2007). Moreover, the average age of women who conceive
through MAR has been increasing over time (author’s elaboration of
data from the Finnish Medical Birth Register). For example, in Finland,
the average age of women who conceived through MAR rose from
around 33 in 1991 to over 35 in 2017. This trend might raise concerns,
as an advanced maternal age at birth (usually defined as a maternal age
of 35 or older at the time of birth), is a well-known risk factor for
adverse birth outcomes. Older mothers were shown to be at higher
risks of low birth weight, preterm birth, perinatal mortality and more
likely to use special care or respiratory care (Hemminki and Gissler,
1996; Aldous and Edmonson, 1993; Jolly et al., 2000; Carolan and
Frankowska, 2011; Klemetti et al., 2013). As the existing evidence on
the link between advanced maternal age and adverse birth outcomes
largely reflects the patterns amongmothers who conceive naturally, the
extent to which these findings can be applied to the patterns among
MAR mothers is unclear. The meaning of an advanced maternal age
could differ depending on the mode of conception, especially given the
distinct health and subfertility conditions among women who conceive
through MAR treatments at all ages (Pinborg et al., 2013; Wennberg
et al., 2016).
The maternal age gradient in adverse birth outcomes in MAR
pregnancies has received limited attention in the literature. The only
two existing studies that have directly analysed the age gradient in
adverse birth outcomes of MAR-conceived children (Tough et al.,
2000; Wennberg et al., 2016) showed that an advanced maternal age
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was not associated with worse birth outcomes among MAR-conceived
children. However, a limitation of these studies is that they were unable
to control for the health and socio-economic characteristics of the
mothers. These are important to consider because olderMARmothers
might represent a selected group of highly educated, higher income
and healthier women compared to younger MARmother and mothers
conceiving naturally. This might confound the results, contributing to
the absence of excess risk observed in older MARmothers (Wennberg
et al., 2016; Barbuscia and Mills, 2017). Therefore, more evidence on
the maternal age gradient in the risk of poorer birth outcomes among
MAR-conceived children is needed.
Exploring the relationship between maternal age and birth outcomes
in MAR pregnancies is especially relevant, as studies that have exam-
ined this association have consistently shown that children conceived
through MAR are at increased risk of adverse birth outcomes, such
as low birth weight (LBW) or preterm birth (Hansen et al., 2005;
Sutcliffe and Ludwig, 2007; Wilson et al., 2011; Pandey et al., 2012;
Hart and Norman, 2013). Although a complete explanation of the
mechanisms underlying the association between the use of MAR and
birth outcomes is still lacking, the existing research has identified
certain risk factors. These include high rates of multiple births (Kalra
and Barnhart, 2011), the MAR treatment techniques themselves (Pin-
borg et al., 2013), and parental characteristics that might predispose
the parents to undergo MAR and that are known risk factors for
adverse birth outcomes, including subfertility and advanced maternal
age (Basso and Baird, 2003; Romundstad et al., 2008; Roseboom, 2018;
Goisis et al., 2019).
Preterm birth and LBW are associated with lower cognitive ability in
childhood as well as other negative outcomes later in life, such as poor
health and cognitive development (Black, et al. 2007; Saigal and Doyle,
2008). It is, therefore, essential that we improve our understanding
of the relevant risk factors for poorer birth outcomes among MAR
children, as this knowledge can help women who are considering
undergoing MAR treatments make better-informed choices. Address-
ing the question of whether and, if so, to what extent giving birth
at an advanced maternal age is associated with an increased risk of
LBW or preterm birth among women who conceive through MAR is
of considerable importance in light of the widespread and increasing
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use of MAR treatments, and of the increasing ages of the women who
conceive through MAR (Ferraretti et al., 2017).
In this study, we compare the association between maternal age and
the risk of adverse birth outcomes among mothers who conceived
thorough MAR and among mothers who conceived naturally using
large-scale and representative population-based data from Finland.We
analyse the maternal age gradient in poorer birth outcomes before
and after adjustment for child and maternal characteristics, such as
twin status, parity and the health condition of the mother before the
pregnancy.
Materials and Methods
Study population
The study utilises data from the Finnish population register and other
administrative registers. The base dataset is a 20% random sample
of households with at least one child aged 0–14 at the end of 2000,
with individual-level information on all household members. The link-
ages between different registers were carried out by Statistics Finland
using unique personal identification numbers (however, data remains
anonymous). In this study, we restricted the data to children who
were born in 1995–2000 because the information (described below)
on whether the child was conceived through MAR or naturally was
only available from 1995 onwards. We excluded cases in which fertility
drugs were used to treat other diagnosed medical conditions, such
as cancer (as indicated by prescription medication purchases in the
special refund category). We excluded births to mothers younger
than age 25 (n=11 041) or older than age 45 (n=267) because the
utilisation of MAR among women younger than age 25 was rare,
and because women in both of these age groups might have used
the drugs for purposes other than the treatment of infertility. We
dropped families with triplets (n=44). Our final sample consisted of
54 623 children, 2624 (4.9%) of whom were conceived through MAR
treatments.
Medically assisted reproduction
We identified children who were conceived through MAR from
purchases of prescription medication, which we retrieved from the
National Prescription Register maintained by the Social Insurance
Institution. The Prescription Register provides information on the day
of purchase, the name and the class of the drug, and the size and the
quantity of the packages. By combining information on each woman’s
purchases of fertility drugs with her child’s date of birth, which was
retrieved from the Finnish Medical Birth Register (MBR), we were
able to identify children conceived through MAR. Four main kinds of
treatments (ovulation induction, artificial insemination, IVF and ICSI)
can be identified through a common pattern of fertility drugs. We
followed the method developed by Hemminki et al. (2003), which has
been found to be reliable, and has been applied by Goisis et al. (2019).
Detailed information on the data linkage can be found in the appendix
of Hemminki’s paper (Hemminki et al., 2003).
Birth outcomes
Information on birth outcomes was extracted from the Finnish MBR.
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We used two dependent variables: whether the child had LBW
(<2500 g at birth) and whether the child was delivered preterm
(<37 weeks of gestation).
Maternal age
The key explanatory variable was maternal age at the birth of the child,
which was also extracted from the MBR. Maternal age was divided into
the following categories: 25–29, 30–34, 35–39 and 40+ years. The age
group 30–34 was the reference category in our analyses, since most of
the MAR births were to women in this age group.
Control variables
We controlled for the child’s characteristics: sex, twin status and
birth order (first, second, third or higher). We controlled for a set
of the mother’s characteristics, which include the mother’s health
before pregnancy (whether the mother had any diagnosed chronic
or acute health conditions, and her number of miscarriages before
the pregnancy), the mother’s socio-economic status (deciles of family
income) and whether themother smoked during pregnancy. To identify
the presence of diagnosed chronic or acute health conditions in the
mother before the pregnancy, we retrieved information from the Social
Insurance Institution on the granting of the right to special reim-
bursement for drugs that are used to treat severe long-term illnesses.
Among these illnesses, we considered the conditions that could be
associated with pregnancy outcomes and/or infertility or subfertility
problems. These conditions were hypertension, thyroid dysfunction,
epilepsy, diabetes, thrombosis, obesity, heart disease, arthritis, dialysis,
transplants, behavioural disorders, coagulation disorders, psychoses
and anaemia. We constructed a binary variable that takes a value of
one if the woman had any of these chronic or acute health conditions
before the pregnancy.
Statistical analysis
To analyse the association between maternal age and birth outcomes,
we estimated linear probability models because of its ease of
interpretation of the results. Coefficients are interpretable as marginal
effects which means that the coefficient of an age group indicates
the percentage-point increase in the probability of poor birth
outcome associated to giving birth in that age group compared to
the baseline (Wooldridge, 2012). Equivalent logistic models provided
similar results, and the odds ratios are shown, for comparison, in
Supplementary Tables SI and SII. We estimated separate models for
the two birth outcomes, and for mothers who conceived either
through MAR or naturally. For each outcome, we estimated four sets
of models. Model 1 introduced controls for the child’s characteristics.
Model 2 controlled for the child’s characteristics while also introducing
controls for the woman’s health before pregnancy. Model 3 controlled
for the child’s characteristics while also introducing controls for
family income and maternal smoking during pregnancy. Model 4
included all of the control variables. Table I shows mothers’ and
infants’ characteristics by the way of conception. The maternal
age coefficients resulting from the linear probability models with
LBW or pre-term birth as the outcome variable are presented in
Table II and Table III, respectively. The coefficients for the control
variables included in the different model specifications are presented
in Supplementary Tables SIII and SIV.
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Table I Background characteristics of mothers and infants born in 1995–2000 in Finland, by whether the child was
conceived through MAR1 or naturally.
MAR Natural conception.......................................................... ............................................................
25–29 30–34 35–39 40+ Total 25–29 30–34 35–39 40+ Total
.......................................................................................................................................................................................
Multiple births (%) 14.8 24.3 20.5 18.7 20.4 1.6 2.6 2.9 2.1 2.3
Girl (%) 46.3 48.9 50.9 47.2 48.6 48.8 49.0 48.8 50.9 48.9
First parity (%) 73.8 62.1 47.2 44.0 60.4 44.5 27.6 18.9 15.6 32.5
Smoking during pregnancy (%) 8.9 4.1 6.5 4.4 6.0 13.5 11.5 12.2 12.1 12
Income deciles (mean) 5.5 6.7 6.8 6.4 6.4 5.1 5.9 6.1 6.0 5.6
Number of miscarriages (mean) 0.2 0.3 0.5 0.6 0.4 0.2 0.3 0.4 0.6 0.3
Diagnosed chronic or acute health condition (%) 2.9 4.1 5.7 11.5 4.7 3.2 3.8 4.8 5.9 3.8
.......................................................................................................................................................................................
% 27 42 24 7 100 41 39 17 3 100
N 717 1091 634 182 2624 21 120 20 089 8989 1801 51 999
1MAR, medically assisted reproduction.
Table II Proportion of and % change in the predicted probability of low birth weight for children conceived through MAR
(n=2624) or naturally (n=51999).
Proportion Model 1: birth
order+multiple
birth+ child’s sex
Model 2:Model 1+
mother’s health
before pregnancy
Model 3:Model
1+ income+ smoking
during pregnancy
Model 4: fully adjusted
.......................................................................................................................................................................................
MAR (n=2624)
......................................................................................................................................................................................
Maternal age % B1 95% CI B 95% CI B 95% CI B 95% CI
25–29 10.7 −0.22 (−3.2 to 2.8) −0.17 (−3.2 to 2.9) −0.49 (−3.6 to 2.6) −0.34(−3.4 to 2.8)
30–34 (ref 1) 13.9 0.0 0.0 0.0 0.0
35–39 10.9 −1.34 (−4.5 to 1.8) −1.4 (−4.5 to 1.7) −1.35 (−4.5 to 1.8) −1.54(−4.7 to 1.6)
40+ 17.6 5.99 (0.49 to 2.57) 5.73 (0.0 to 11.5) 5.99 (0.2 to 11.8) 5.47 (−0.2 to 11.2)
......................................................................................................................................................................................
Natural conception (n=51 999)
......................................................................................................................................................................................
25–29 3.0 −0.55 (−0.91 to −0.19) −0.54 (−0.89 to −0.18) −0.7 (−1.06 to −0.33) −0.65(−1.02 to −0.29)
30–34 (ref ) 3.4 0.0 0.0 0.0 0.0
35–39 4.3 1.08 (0.58 to 1.58) 1.06 (0.55 to 1.56) 1.09 (0.59 to 1.60) 1.02 (0.52 to 1.52)
40+ 4.4 1.53 (0.49 to 2.57) 1.47 (0.43 to 2.51) 1.55 (0.52 to 2.59) 1.34 (0.29 to 2.38)
Results from linear probability models. Coefficients denote percentage point changes in the predicted probability of low birth weight.
1Reference groups for all models is maternal age between 30 and 34 years.
Results
The mothers’ characteristics and the infants’ characteristics and out-
comes differed considerably depending on whether the birth was after
MAR or was naturally conceived (Table I). First, higher proportions of
mothers who conceived through MAR gave birth at older ages than of
mothers who conceived naturally: among the MAR mothers, 24% gave
birth at ages 35–39 and 7% gave birth at ages 40 and older, while among
the mothers who conceived naturally, the corresponding shares were
17 and 3%. Second, in line with findings reported in the literature, the
MAR children were more likely to be twins and were more likely to be
first born. Third, in terms of maternal socio-economic characteristics,
the MAR mothers had a higher average income and were less likely
to have smoked during pregnancy than the mothers who conceived
naturally. TheMARmothers were also more likely to have experienced
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a miscarriage and to have suffered from a chronic disease than the
mothers who conceived naturally.
The incidence of both LBW and preterm was consistently higher
among MAR-conceived children than among naturally conceived chil-
dren higher (overall 12.6% LBW among MAR children compared to
3.4% among NC children; 14.2% preterm birth among MAR children
compared to 4.9% among NC children) at all maternal ages. However,
while it increased with the age of the mother among the naturally con-
ceived children, the pattern was less clear among the MAR-conceived
children (Tables II and III).
Linear probability models
The results from the linear probability models suggest that, despite
the older maternal ages and the higher prevalence of poor birth
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Table III Proportion of and % change in the predicted probability of preterm birth for children conceived through MAR
(n=2624) or naturally (n=51999).
Proportion Model 1: birth
order+multiple
birth+ child’s sex
Model 2:Model 1+
mother’s health
before pregnancy
Model 3:Model
1+ income+ smoking
during pregnancy
Model 4: fully adjusted
.......................................................................................................................................................................................
MAR (n=2624)
......................................................................................................................................................................................
Maternal age % B 95% CI B 95% CI B 95% CI B 95% CI
25–29 12.5 −0.32 (−3.91 to 3.27) −0.26 (−3.85 to 3.33) −0.44 (−4.10 to 3.22) −0.27 (−3.94 to 3.40)
30–34 (ref ) 15.6 0.0 0.0 0.0 0.0
35–39 13.2 −0.57 (−4.39 to 8.94) −0.65 (−4.47 to 3.17) −0.66 (−4.47 to 3.16) −0.86 (−4.69 to 2.97)
40+ 15.9 2.59 (−3.76 to 8.94) 2.24 (−4.09 to 8.56) 2.61 (−3.75 to 8.97) 2.02 (−4.30 to 8.33)
......................................................................................................................................................................................
Natural conception (n=51999)
......................................................................................................................................................................................
25–29 4.5 −0.27 (−0.70 to 1.16) −0.24 (−0.67 to 0.19) −0.43 (−0.87 to 0.01) −0.35 (−0.79 to 0.09)
30–34 (ref ) 4.6 0.0 0.0 0.0 0.0
35–39 5.8 1.30 (0.71 to 1.90) 1.26 (0.66 to 1.85) 1.33 (0.74 to 1.93) 1.21 (0.62 to 1.81)
40+ 6.1 1.91 (0.71 to 3.11) 1.81 (0.61 to 3.00) 1.95 (0.75 to 3.15) 1.61 (0.41 to 2.81)
Results from linear probability models.
outcomes observed among the MAR pregnancies, maternal age was
not associated with the probability of LBW or preterm birth among
the MAR births (Tables II and III and Figs 1 and 2).
Among the mothers who conceived through MAR, those at both
younger maternal ages (25–29) and at maternal ages between 35 and
39 had a lower risk of giving birth to a LBW child than those in the
reference age group (30–34). However, these associations were small
inmagnitude, and the differences in the risk ranged from slightly positive
to negative associations (respectively β =−0.22, 95% CI =−3.2 to 2.8
and β =−1.34, 95% CI =−4.5 to 1.8; Table II). The coefficients did
not change with the inclusion of maternal characteristics in Models
2 through 4. On the contrary, the risk of LBW was substantially
increased for mothers aged 40 or older (β =5.99, 95% CI = 0.2 to
11.8). The association was only slightly attenuated after adjustment for
the mother’s health before pregnancy and socio-economic indicators:
in the fully adjusted model, the probability of giving birth to a LBW
child after MAR was 5.47 (95% CI =−0.2 to 11.2) percentage points
higher at maternal ages 40+ than at ages 30–34.
By contrast, among mothers who conceived naturally, the results
showed a clear age gradient in the probability of giving birth to a LBW
child. The probability of giving birth to a LBW child was 0.55 (95%
CI =−0.91 to −0.19) percentage points lower at maternal ages 25–
29 than at the reference group ages, while the probability of giving
birth to a LBW child was higher at maternal ages older than at the
reference category ages (β =1.08, 95% CI = 0.58 to 1.58 for ages
35–39 and β =1.53, 95% CI = 0.49 to 2.57 for ages 40 or older in
Model 1). The association was only slightly attenuated on adjustment
for the mothers’ health conditions and socio-economic indicators (for
example, to β =1.02, CI = 0.52 to 1.52 for the 35–39 age group).
Among the MAR mothers, maternal age was not associated to an
increased risk of preterm birth at ages 25–39, while the risk of preterm
birth was 2.59 percentage points higher at maternal ages 40+ than
at ages 25–39 (Table III). However, a relatively wide range of risk
differences, running from a negative association to a substantial positive
.
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association, was compatible with our data (95%CI:−3.76 to 8.94). The
coefficients of maternal age were only slightly reduced after adjustment
for the mothers’ pre-pregnancy health conditions and socio-economic
indicators. The age gradient for the mothers who conceived naturally
was similar to that observed for LBW.
These results suggest that although an age gradient in the probability
of poorer birth outcomes at birth was clearly observable among the
mothers who conceived naturally, with the probability of a LBW or
a preterm birth increasing with maternal age across all age groups,
no such age gradient was observable among the MAR mothers. The
probability of giving birth to a LBW or a preterm child was higher only
for the MAR mothers aged 40 or older, while the risk of an adverse
birth outcome was not associated with maternal age for the MAR
mothers younger than age 40. We also ran the same linear probability
models (Model 1) on the whole sample and included the interactions
between MAR and maternal age groups (Supplementary Table SV).
The results of joint tests on the interactions showed that the age
gradient of the mothers who conceived through MAR and of the
mothers who conceived naturally differed significantly for low birth
weight (P =0.078), but not for premature birth (P =0.359).
As a robustness check, we estimated the models while excluding
multiple births. The results for both low birth weight and preterm births
among singletons (Supplementary Table SVI) support the main study
arguments.
Discussion
Our results, which are based on a large representative sample of
Finnish women, show that an increasing maternal age was not asso-
ciated with worse birth outcomes for MAR mothers who were aged
25–39 at the time of birth. These results are in line with Wennberg
et al. (2016), who found that there was no significant increase in the
risk of adverse birth outcomes with older maternal age among MAR
pregnancies. Differently from their results, which showed no increased
D
ow
nloaded from
 https://academ
ic.oup.com
/hum
rep/article-abstract/35/1/212/5713535 by U
niversity of H
elsinki and H
U
 C
entral H
ospital user on 01 July 2020
Maternal age gradient in MAR children’s birth outcomes 217
Figure 1 Predicted probability of low birth weight for children conceived through MAR (n=2624) and naturally (n=51 999) in
Finland in 1995–2000 by maternal age categories.Results from adjusted linear probability models. MAR, medically assisted reproduction; NC,
natural conception.
Figure 2 Predicted probability of preterm birth for children conceived through MAR (n=2624) and naturally (n=51 999) in
Finland in 1995–2000 by maternal age categories.Results from adjusted linear probability models.
risk for the whole age range considered (up to 46 years), we also
observed an increased risk for mothers aged 40 or older. However, in
.
.
.
.
our sample, only a small proportion (7%, 182 women) of all mothers
who used MAR to conceive were aged 40+, which means that we only
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observe an age-related increase in the risk of adverse outcomes for a
limited proportion of the studied population. Importantly, in this study,
we were able to show that these results are robust to adjustment for
the mothers’ socio-economic characteristics. This is important, in light
of the potential selected profile of MAR mothers (Chambers et al.,
2014; Barbuscia and Mills, 2017) and especially of those who conceive
at a more advanced age. Older MAR mothers might thus represent a
group that has higher incomes, is better educated and adopt healthier
lifestyles during pregnancy than many older SC mothers, which might
explain why no adverse birth outcome risk excess was observed in
previous studies (Wennberg et al. 2016). We were also able to con-
trol for maternal health before the pregnancy. Although the available
information did not allow us to control for all health characteristics that
might be associated with both birth outcomes and the use of MAR
treatments, our measure was able to capture the presence of a series
of important chronic or acute health conditions (Cleary-Goldman et al.
2005) that could confound the results.
The results indicate that there was a clear age gradient in birth out-
comes among mothers who conceived naturally, with the probability
of poorer birth outcomes increasing with the age of the mother; this
finding is also in line with the existing literature (Aldous and Edmonson,
1993; Hemminki and Gissler, 1996; Jolly et al., 2000; Carolan and
Frankowska, 2011, Klemetti et al., 2016; Goisis et al., 2017). For all
births, the link between oldermaternal age and adverse birth outcomes
is partly explained by subfertility (Leridon, 2004; Thomson et al., 2005;
Kondapalli and Perales-Puchalt, 2013; Somigliana et al., 2016). A pos-
sible interpretation of our finding that there was no age gradient in
adverse birth outcomes prior to age 40 among the MAR mothers is
that, within this group, subfertility was experienced at all ages, including
at younger ages.
It is also possible that the women who seek MAR treatments at
younger ages differ substantially from the women who seek MAR
treatments at older ages. Moreover, the women’s reasons for accessing
these treatments might differ by age as well. The women who use
MAR treatments at relatively young ages (35 or younger) may have
health/subfertility conditions that they were informed of early in
life, which could indicate that they suffer from more serious health
problems than the women who access MAR treatments at older ages.
This selection would bias our results by increasing the incidence of
adverse birth outcomes among younger mothers and would therefore
mask the more typical age gradient found for naturally conceived
births. Unfortunately, we were not able to include any controls for
the reproductive conditions linked to the use of MAR as they are not
included in the category for special reimbursement, and information on
the specific diagnoses behind other prescriptions is not available in the
medication registry. However, our descriptive statistics suggest that this
was not a serious issue in our analysis, as the women who conceived
through MAR at younger ages do not seem to differ substantially from
their counterparts who conceived at older ages in terms of their health
conditions or experience of miscarriages.
However, the strongly increased risk of adverse birth outcomes
found among the women who conceived through MAR at age 40 or
older might be partly attributable to their more prolonged exposure
to the stress associated with undergoing MAR treatment. Indeed, an
older maternal age might be associated with having undergone a series
of unsuccessful treatments before the treatment that resulted in a live
birth. The link between maternal stress and the risk of a preterm birth
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or a LBW has been reported in the literature for naturally conceived
births (e.g. Smits et al. 2006; Torche, 2011). Mothers aged 40 or
older might also represent a particularly selected subgroup in terms
of their health conditions or other characteristics not captured by our
control variables. These characteristics might help to explain why these
mothers took a long time to conceive, and why they faced a much
higher risk of poorer birth outcomes. In addition, conceiving at an
older age might imply that the mother used a more invasive treatment,
such as IVF and ICSI, whereas a younger mother may have achieved
pregnancy through ovulation induction. Finally, it is possible that the
explanation for this association is multifactorial, and that the increased
risk of adverse birth outcomes observed among MAR mothers aged
40 or older is the result of the cumulative interactive effects of the
use of MAR treatments and advanced maternal age. The medical
literature has identified age 40 as a clinically meaningful threshold for a
higher probability of adverse birth outcomes (Mills and Lavender, 2007;
Klemetti et al., 2016).
Strengths and limitations
In the interpretation of the results, some methodological issues need
to be considered. First, we could not reliably distinguish between
the different kinds of MAR treatments used, which include less inva-
sive treatments that are less strongly associated with adverse birth
outcomes, (De Geyter et al., 2018), such as ovulation induction, as
well as more invasive treatments, such as IVF. Because we did not
have access to the National Procedure Register, we could not reliably
distinguish IVF treatments from the less invasive treatments, which
led us to underestimate the percentage of children conceived by IVF
by about 10% (Goisis et al. 2019). Despite these data limitations, we
conducted robustness checks to test whether our results could be
driven by differences in the types of MAR treatments that younger and
older mothers undergo. We estimated the models while adjusting for
treatment type, and the results were unchanged. We estimated the
models separately for the group of children conceived by IVF (40% of
all MAR births), and the results supported the main study argument.
This evidence suggests that our results are unlikely to be driven by
differences in the types of treatment used by younger and older MAR
mothers. Second, our measures of maternal health before pregnancy
did not cover all of the health conditions that might be relevant for both
maternal age at birth and birth outcomes. This could explain why this
measure only partially attenuated the increased risk at ages 40+. Third,
we did not have information about the duration of the treatments,
which might be associated with both maternal age and birth outcomes.
Overall, this study represents an important contribution to the litera-
ture on birth outcomes after MAR.We show that maternal age was not
associated with adverse birth outcomes below age 40 but was strongly
associated with adverse birth outcomes at ages 40+. We also show
that this increased risk was only partly explained by the mother’s health
condition or by other potentially crucial factors, such as the mother’s
income and whether she smoked during pregnancy. Having a better
understanding of the birth outcomes of MAR mothers at advanced
ages is crucial in light of the increasing number of women and couples
undertaking MAR at older ages. More conclusive evidence about the
risks associated with very advanced maternal ages (≥40) will enable
the many women and couples with infertility or subfertility problems to
make well-informed choices about the use of MAR treatments. When
interpreting our results, it is important to bear in mind that our sample
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only includes women who succeeded in conceiving through MAR, and
who had a pregnancy that ended in a live birth. The live birth rate after
MAR decreases dramatically with age (among others, see Ferraretti
et al., 2017). Therefore, our results do not suggest that maternal age is
irrelevant for the outcomes of MAR, or that it should not be considered
when making decisions about MAR treatments. Instead, our findings
suggest that maternal age is not necessarily associated with a higher
incidence of LBW or preterm deliveries in the MAR pregnancies of
women under age 40.
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